Lp(a) antibody (Middle Region)
-
- Target
- Lp(a) (Lipoprotein (Lp(a)))
-
Binding Specificity
- Middle Region
-
Reactivity
- Human
-
Host
- Rabbit
-
Clonality
- Polyclonal
-
Conjugate
- This Lp(a) antibody is un-conjugated
-
Application
- Western Blotting (WB)
- Purification
- Purified
- Immunogen
- Lp (a) antibody was raised in rabbit using the middle region of LPA as the immunogen
-
-
- Application Notes
-
WB: 0.2-1 µg/mL
Optimal conditions should be determined by the investigator. - Comment
-
Lp (a) Blocking Peptide, catalog no. 33R-9718, is also available for use as a blocking control in assays to test for specificity of this Lp (a) antibody
- Restrictions
- For Research Use only
-
- Format
- Lyophilized
- Concentration
- Lot specific
- Buffer
- Lyophilized powder. Add 50 µL of distilled water. Final antibody concentration is 1 mg/mL in PBS buffer.
- Handling Advice
- Avoid repeated freeze/thaw cycles.
- Storage
- 4 °C/-20 °C
- Storage Comment
- Store at 4 °C, following reconstitution, aliquot and store at -20 °C.
-
- Target
- Lp(a) (Lipoprotein (Lp(a)))
- Alternative Name
- Lp (A)
- Background
- LPA is a serine proteinase that inhibits the activity of tissue-type plasminogen activator I. The protein constitutes a substantial portion of lipoprotein(a) and is proteolytically cleaved, resulting in fragments that attach to atherosclerotic lesions and promote thrombogenesis. Elevated plasma levels of this protein are linked to atherosclerosis. Depending on the individual, the protein contains 2-43 copies of kringle-type domains. Synonyms: Polyclonal Lp (a) antibody, Anti-Lp (a) antibody, lipoprotein, LPA antibody, LP antibody, AK38 antibody, APOA antibody, LPA antibody.
-